Results 91 to 100 of about 47,567 (220)
Pediatric Blood &Cancer, Volume 73, Issue 4, April 2026.ABSTRACT Background B‐cell lymphoblastic lymphoma (B‐LBL) represents a rare variety of non‐Hodgkin lymphoma, with limited research on its biology, progression, and management. Methods A retrospective analysis was performed on the clinical characteristics of 256 patients aged ≤18 years who received treatment under the China Net Childhood Lymphoma (CNCL)‐
Zhijuan Liu +20 more
wiley +1 more source
Acute Lymphoblastic Leukemia Presenting as Acute Vogt-Koyanagi-Harada Syndrome
Case Reports in Ophthalmology, 2020 We aimed to describe a case of acute lymphoblastic leukemia (ALL) that initially presented and was managed as Vogt-Koyanagi-Harada syndrome (VKH). A 62-year-old man was referred for vision loss starting 1 week ago.
Narges Hassanpoor +1 more
doaj +1 more source
Biotechnology Journal, Volume 21, Issue 4, April 2026.Graphical Abstract and Lay Summary This article demonstrates how capacitance probes can be applied to single‐patient (autologous) manufacturing processes within the cell and gene therapy (CGT) industry by using CAR‐T cells as a case study. Current CGT processes require operator intervention to sample, monitor and harvest each batch which increases ...
Ivano Luigi Colao +4 more
wiley +1 more source
Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus [PDF]
, 2016 Although there are high survival rates for children with acute lymphoblastic leukaemia, their outcome is often counterbalanced by the burden of toxic effects.
Attarbaschi, Andishe +20 more
core +2 more sources
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma with severe eosinophilia, in a young adult patient
, 2020 Introduction: Acute lymphoblastic leukemia (ALL) of B cells, is the most common subtype of ALL in children.(1,2) ALL that presents as hypereosinophilia in peripheral blood, is very rare and the incidence is <1%.(3) Case Report: In this case, is presented a girl, 25 year old girl, initially diagnosed as community acquired pneumonia and leukemoid ...
Tello-Vera, Stalin, Novoa-Pérez, Karla
openaire +1 more source
Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia [PDF]
, 2016 Deregulated expression of the type I cytokine receptor, CRLF2, is observed in 5–15% of precursor B-cell acute lymphoblastic leukaemia (B-ALL). We aimed to determine the clinical and genetic landscape of those with IGH-CRLF2 or P2RY8-CRLF2 (CRLF2-r) using
Campbell, PJ +13 more
core +1 more source
T-Lymphoblastic Lymphoma with an Unusual t(8;14)(q24;q11) – Case Report [PDF]
, 2010 Cytogenetic abnormalities seen at presentation of acute lymphoblastic leukemia or lymphoblastic lymphoma (ALL/ LBL) are associated with distinct clinical and hematologic disease entities.
Ika Kardum-Skelin +5 more
core +1 more source
ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms [PDF]
, 2019 ZEB1 and ZEB2 are structurally related E-box binding homeobox transcription factors that induce epithelial to mesenchymal transitions during development and disease.
Berx, Geert +12 more
core +3 more sources
Journal of Hematology & Oncology, 2016 Background Acute lymphoblastic leukemia (ALL) is an aggressive malignant disorder of lymphoid progenitor cells in both children and adults. Although improvements in contemporary therapy and development of new treatment strategies have led to dramatic ...
Pei-Jie Shi +4 more
doaj +1 more source
Biological and clinical characteristics of ETV6::RUNX1‐like ALL
HemaSphere, Volume 10, Issue 4, April 2026.Abstract ETV6::RUNX1‐like ALL is defined by a gene expression signature similar to that of ETV6::RUNX1‐positive ALL and absence of all genetic subtype‐defining aberrations, including the ETV6::RUNX1 fusion. Within the International BFM Study Group, we assembled and analyzed a cohort of 100 patients (including 97 children) with ETV6::RUNX1‐like ALL.
Marketa Zaliova +32 more
wiley +1 more source